참고문헌
- Bae YH, Ding Z, Zou L, et al (2009). Loss of profilin-1 expression enhances breast cancer cell motility by Ena/VASP proteins. J Cell Physiol, 219, 354-64. https://doi.org/10.1002/jcp.21677
- Barone I, Brusco L, Gu G, et al (2011). Loss of Rho GDIalpha and resistance to tamoxifen via effects on estrogen receptor alpha. Natl Cancer Inst, 103, 538-52. https://doi.org/10.1093/jnci/djr058
- Brenton JD, Carey LA, Ahmed AA, Caldas C (2005). Molecular classification and molecular forecasting of breast cancer: ready for clinical application? Clin Oncol, 23, 7350-60. https://doi.org/10.1200/JCO.2005.03.3845
- Carragher NO, Fonseca BD, Frame MC (2004). Calpain activity is generally elevated during transformation but has oncogene-specific biological functions. Neoplasia, 6, 53-73. https://doi.org/10.1016/S1476-5586(04)80053-8
- Chua PJ, Lee EH, Yu Y, et al (2010). Silencing the Peroxiredoxin III gene inhibits cell proliferation in breast cancer. Int J Oncol, 36, 359-64.
- Dawling S, Roodi N, Mernaugh RL, Wang X, Parl FF (2001). Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms. Cancer Res, 61, 6716-22.
- Ding Z, Joy M, Bhargava R, et al (2013). Profilin-1 downregulation has contrasting effects on early vs late steps of breast cancer metastasis. Oncogene.???
- Gast MC, Schellens JH, Beijnen JH (2009). Clinical proteomics in breast cancer: a review. Breast Cancer Res Treat, 116, 17-29. https://doi.org/10.1007/s10549-008-0263-3
- Graff JR, Konicek BW, Vincent TM, et al (2007). Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity. J Clin Invest, 117, 2638-48. https://doi.org/10.1172/JCI32044
- Grant AG, Flomen RM, Tizard ML, Grant DA (1992). Differential screening of a human pancreatic adenocarcinoma lambda gt11 expression library has identified increased transcription of elongation factor EF-1 alpha in tumour cells. Int J Cancer, 50, 740-5. https://doi.org/10.1002/ijc.2910500513
- Hoj BR, la Cour JM, Mollerup J, Berchtold MW (2009). ALG-2 knockdown in HeLa cells results in G2/M cell cycle phase accumulation and cell death. Biochem Biophys Res Commun, 378, 145-8. https://doi.org/10.1016/j.bbrc.2008.11.021
-
Hooshmand S, Ghaderi A, Yusoff K, et al (2013). Downregulation of
$RhoGDI\alpha$ increased migration and invasion of ER (+) MCF7 and ER (-) MDA-MB-231 breast cancer cells. Cell Adh Migr, 7, 297-303. https://doi.org/10.4161/cam.24204 - Hu LD, Zou HF, Zhan SX, Cao KM (2007). Biphasic expression of RhoGDI2 in the progression of breast cancer and its negative relation with lymph node metastasis. Oncol Rep, 17, 1383-9.
- Ji Y, Olson J, Zhang J, et al (2008). Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms. Cancer Res, 68, 5997-6005. https://doi.org/10.1158/0008-5472.CAN-08-0043
- Kanaujiya JK, Lochab S, Kapoor I, et al (2013). Proteomic identification of Profilin1 as a corepressor of estrogen receptor alpha in MCF7 breast cancer cells. Proteomics, 13, 2100-12. https://doi.org/10.1002/pmic.201200534
- Lai TC, Chou HC, Chen YW, et al (2010). Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis. J Proteome Res, 9, 1302-22. https://doi.org/10.1021/pr900825t
- Lee S, Terry D, Hurst DR, Welch DR, Sang QX (2011). Protein signatures in human MDA-MB-231 breast cancer cells indicating a more invasive phenotype following knockdown of human endometase/matrilysin-2 by siRNA. J Cancer, 2, 165-76. https://doi.org/10.7150/jca.2.165
- Libertini SJ, Robinson BS, Dhillon NK, et al (2005). Cyclin E both regulates and is regulated by calpain 2, a protease associated with metastatic breast cancer phenotype. Cancer Res, 65, 10700-8. https://doi.org/10.1158/0008-5472.CAN-05-1666
- Lin M, van Golen KL (2004). Rho-regulatory proteins in breast cancer cell motility and invasion. Breast Cancer Res Treat, 84, 49-60. https://doi.org/10.1023/B:BREA.0000018424.43445.f3
- Mommers EC, van Diest PJ, Leonhart AM, Meijer CJ, Baak JP (1999). Balance of cell proliferation and apoptosis in breast carcinogenesis. Breast Cancer Res Treat, 58, 163-9. https://doi.org/10.1023/A:1006396103777
- Nagaraja GM, Othman M, Fox BP, et al (2006). Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics. Oncogene, 25, 2328-38. https://doi.org/10.1038/sj.onc.1209265
- Niemi M, Kervinen K, Kiviniemi H, et al (2000). Apolipoprotein E phenotype, cholesterol and breast and prostate cancer. J Epidemiol Community Health, 54, 938-9. https://doi.org/10.1136/jech.54.12.938
- Pan J, Sun LC, Tao YF, et al (2011). ATP synthase ecto-alpha-subunit: a novel therapeutic target for breast cancer. J Transl Med, 9, 211. https://doi.org/10.1186/1479-5876-9-211
- Pluta P, Cebula-Obrzut B, Ehemann V, et al (2011). Correlation of Smac/DIABLO protein expression with the clinico-pathological features of breast cancer patients. Neoplasma, 58, 430-5. https://doi.org/10.4149/neo_2011_05_430
- Pola C (2012). Cancer: Antitumor duality of ApoE. Nature Medicine, 18, 1752.
- Reis-Filho JS, Lakhani SR (2003). The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions. Breast Cancer Res, 5, 313-9. https://doi.org/10.1186/bcr650
- Rho SB, Song YJ, Lim MC, et al (2012). Programmed cell death 6 (PDCD6) inhibits angiogenesis through PI3K/mTOR/p70S6K pathway by interacting of VEGFR-2. Cell Signal, 24, 131-9. https://doi.org/10.1016/j.cellsig.2011.08.013
- Ryu J, Song J, Heo J, et al (2011). Cross-regulation between protein L-isoaspartyl O-methyltransferase and ERK in epithelial mesenchymal transition of MDA-MB-231 cells. Acta Pharmacol Sin, 32, 1165-72. https://doi.org/10.1038/aps.2011.94
- Salicioni AM, Xi M, Vanderveer LA, et al (2000). Identification and structural analysis of human RBM8A and RBM8B: two highly conserved RNA-binding motif proteins that interact with OVCA1, a candidate tumor suppressor. Genomics, 69, 54-62. https://doi.org/10.1006/geno.2000.6315
- Sarvaiya HA, Yoon JH, Lazar IM (2006). Proteome profile of the MCF7 cancer cell line: a mass spectrometric evaluation. Rapid Commun Mass Spectrom, 20, 3039-55. https://doi.org/10.1002/rcm.2677
- Shida A, Fujioka S, Takahashi N, et al (2013). Reduced expression of Rho GDP dissociation inhibitor 2 mRNA is associated with lymph node metastasis in gastric carcinoma. Oncol Lett, 6, 463-7. https://doi.org/10.3892/ol.2013.1379
- Sofi GN, Sofi JN, Nadeem R, et al (2012). Estrogen receptor and progesterone receptor status in breast cancer in relation to age, histological grade, size of lesion and lymph node involvement. Asian Pac J Cancer Prev, 13, 5047-52. https://doi.org/10.7314/APJCP.2012.13.10.5047
- Srisomsap C, Sawangareetrakul P, Subhasitanont P, et al (2004). Proteomic analysis of cholangiocarcinoma cell line. Proteomics, 4, 1135-44. https://doi.org/10.1002/pmic.200300651
- Strande V, Canelle L, Tastet C, et al (2009). The proteome of the human breast cancer cell line MDA-MB-231: Analysis by LTQ-Orbitrap mass spectrometry. Proteomics Clin, 3, 41-50. https://doi.org/10.1002/prca.200800083
- Stresing V, Baltziskueta E, Rubio N, et al (2013). Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungs. Oncogene, 32, 724-35. https://doi.org/10.1038/onc.2012.93
- Suhane S, Berel D, Ramanujan VK (2011). Biomarker signatures of mitochondrial NDUFS3 in invasive breast carcinoma. Biochem Biophys Res Commun, 412, 590-95. https://doi.org/10.1016/j.bbrc.2011.08.003
- Tari AM, Hung MC, Li K, Lopez-Berestein G (1999). Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells. Oncogene, 18, 1325-32. https://doi.org/10.1038/sj.onc.1202422
- Undyala VV, Dembo M, Cembrola K, et al (2008). The calpain small subunit regulates cell-substrate mechanical interactions during fibroblast migration. J Cell Sci, 121, 3581-8. https://doi.org/10.1242/jcs.036152
- Wilkins MR, Pasquali C, Appel RD, et al (1996). From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis. Biotechnology, 14, 61-5. https://doi.org/10.1038/nbt0196-61
- Yamada Y, Arao T, Gotoda T, et al (2008). Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples. Cancer Sci, 99, 2193-9. https://doi.org/10.1111/j.1349-7006.2008.00935.x
- Yan Y, Mahotka C, Heikaus S, et al (2004). Disturbed balance of expression between XIAP and Smac/DIABLO during tumour progression in renal cell carcinomas. Br J Cancer, 91, 1349-57. https://doi.org/10.1038/sj.bjc.6602127
- Zhang SJ, Hu Y, Qian HL, et al (2013). Expression and significance of ER, PR, VEGF, CA15-3, CA125 and CEA in judging the prognosis of breast cancer.. Asian Pac J Cancer Prev, 14, 3937-40. https://doi.org/10.7314/APJCP.2013.14.6.3937
피인용 문헌
- Protein Profiles Associated with Anoikis Resistance of Metastatic MDA-MB-231 Breast Cancer Cells vol.17, pp.2, 2016, https://doi.org/10.7314/APJCP.2016.17.2.581
- Fatty acid synthase regulates the chemosensitivity of breast cancer cells to cisplatin-induced apoptosis vol.22, pp.6, 2017, https://doi.org/10.1007/s10495-017-1366-2
- Sphingomyelin synthase 2 promotes an aggressive breast cancer phenotype by disrupting the homoeostasis of ceramide and sphingomyelin vol.10, pp.3, 2019, https://doi.org/10.1038/s41419-019-1303-0